BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
17.29
+0.24 (1.41%)
At close: May 29, 2026, 4:00 PM EDT
17.68
+0.39 (2.26%)
After-hours: May 29, 2026, 7:16 PM EDT
BioAge Labs Market Cap
BioAge Labs has a market cap or net worth of $768.59 million as of May 29, 2026. Its market cap has increased by 470.19% in one year.
Market Cap
768.59M
Enterprise Value
387.75M
1-Year Change
470.19%
Ranking
Category
Stock Price
$17.29
Market Cap Chart
Since the IPO on September 26, 2024, BioAge Labs's market cap has increased from $615.01M to $768.59M, an increase of 24.97%. That is a compound annual growth rate of 14.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 768.59M | 62.03% |
| Dec 31, 2025 | 474.36M | 128.54% |
| Dec 31, 2024 | 207.56M | -66.25% |
| Sep 26, 2024 | 615.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evotec SE | 1.10B |
| Collegium Pharmaceutical | 1.09B |
| Cronos Group | 1.07B |
| Xeris Biopharma Holdings | 1.06B |
| Alvotech | 1.05B |
| Pacira BioSciences | 913.66M |
| Eton Pharmaceuticals | 834.10M |
| Amphastar Pharmaceuticals | 831.15M |